GenScript is excited to announce our presence at the 22nd annual CIMT Meeting, taking place at Rheingoldhalle Congress Center, Mainz, Germany, from May 12th-14th, 2025.

As the Europe's largest science-driven, not-for-profit event, the CIMT Annual Meeting invites international participants for high-level scientific exchange, collaboration and discussion focused on cancer immunotherapy.

Why Visit GenScript at CIMT 2025?

At GenScript, we are driving the future of cancer immunotherapy with innovative tools and services that help accelerate research and development.

Discover how our solutions can enhance your immuno-oncology projects:

01/ Precision Gene Editing for Targeted Therapies

Discover how our CRISPR-based gene editing technologies can be leveraged to develop targeted treatments that enhance the specificity and effectiveness of your immuno-oncology research.

02/ Innovative CAR-T and TCR-T Engineering

Learn how our advanced engineering of CAR-T and TCR-T cells can improve the targeting and efficacy of your cancer immunotherapy.

03/ Accelerated Antibody Production

Explore how our optimized antibody production processes can speed up the development of antibodies, facilitating quicker progression from research to clinical.

An Extra Reason to Visit Us

To further enhance your CIMT Annual Meeting experience, we're offering a special gift: an exclusive Mainz City Bag.

Simply fill out a short form and claim your bag at our booth.

Please note: The Mainz City Bag is available only for pick-up on-site at the CIMT Annual Meeting and is limited to stock on hand.

Our Experts at CIMT 2025

Lyla Li

Lyla Li

Sales Account Manager

Nikolett Nagy

Nikolett Nagy

Sales Account Manager

Robert Ford

Robert Ford

Field Application Scientist

banner

GenScript is here to support your cancer immunotherapy needs with cutting-edge solutions and expertise to advance your research and production goals.

Immuno Oncology Solutions | GenScript